Last Update

2016-08-11T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Peter Glick?

Mr. Peter H. Glick

Direct Phone: (978) ***-****       

Email: p***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Ampersand Venture Management 2003 LLC

55 William Street, Sutie 240

Wellelsey, Massachusetts 02481

United States

Company Description

Ampersand is a middle market private equity firm with a focus on growth equity investments in the healthcare sector. Over the past two decades, Ampersand has managed more than $1 billion in private equity partnerships. Ampersand leverages its unique blend ... more

Find other employees at this company (20)

Background Information

Employment History

Executive Chairman

Dynex Technologies , Inc.

President

Cohesive Technologies Inc.

President

Primedica Corporation

Management Consultant

Bain & Company

Director

CRI Worldwide LLC

Affiliations

Chairman
Blue Sky BioServices

Chairman
Magellan Biosciences Inc

Chairman
ChanTest Corporation

Director
IBT

Education

B.S.

Ecomomics

Wharton

BS

Economics

The Wharton School at the University of Pennsylvania

Bachelor's degree

Economics

Wharton School at the University of Pennsylvania

M.S.

Management

MIT

M.S.

Management

Sloan School at MIT

MS

Management

MIT's Sloan School

Master's degree

Management

Sloan School at the Massachusetts Institute of Technology

Master's degree

Management

Sloan School of Management at Massachusetts Institute of Technology

master's degree

management

The Sloan School of Management at Massachusetts Institute of Technology

Web References (87 Total References)


Magellan Diagnostics

www.magellandx.com [cached]

Peter Glick, Chairman of the Board

Peter is a life sciences investor and serial entrepreneur focused on clinical diagnostics, contract research organizations, and scientific instruments. He currently serves as Chairman of Magellan Diagnostics, Dynex Technologies, Agilux Laboratories, and Blue Sky Bioservices. He is a Venture Partner at Ampersand Capital Partners, where he previously served as a General Partner.
Prior to Ampersand, he was CEO of Cohesive Technologies, a high throughput chromatography company that was acquired by Thermo Fisher, and President of Primedica Corporation, a preclinical CRO acquired by Charles River Laboratories.
Earlier in his career, Peter was VP of Corporate Development at Genzyme Transgenics Corporation, and a management consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from The Wharton School at the University of Pennsylvania.


Magellan Diagnostics

magellandx.com [cached]

Peter Glick, Chairman of the Board

Peter is a life sciences investor and serial entrepreneur focused on clinical diagnostics, contract research organizations, and scientific instruments. He currently serves as Chairman of Magellan Diagnostics, Dynex Technologies, Agilux Laboratories, Blue Sky Bioservices, and Ekam Imaging. He is a Venture Partner at Ampersand Capital Partners, where he previously served as a General Partner.
Prior to Ampersand, he was CEO of Cohesive Technologies, a high throughput chromatography company that was acquired by Thermo Fisher, and President of Primedica Corporation, a preclinical CRO acquired by Charles River Laboratories.
Earlier in his career, Peter was VP of Corporate Development at Genzyme Transgenics Corporation, and a management consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from The Wharton School at the University of Pennsylvania.


Management | Ekam Imaging

www.ekamimaging.com [cached]

Peter Glick, Chairman, is a serial entrepreneur and life sciences investor. As President of Primedica Corporation, he led a preclinical CRO to revenues of $72MM and a sale to Charles River Laboratories. As CEO of Cohesive Technologies, he led the placement of hundreds of advanced chromatography systems into high throughput laboratories and a sale to Thermo Fisher Scientific. He is currently Chairman of Agilux Laboratories and Blue Sky Biotech, and has served as a General Partner at Ampersand Ventures.


Transaction Advisory

www.providenthp.com [cached]

Peter Glick, General Partner at Ampersand Ventures, added, "We're very excited to become Blue Sky's partner.


Magellan Diagnostics

www.magellanbio.com [cached]

Peter Glick, Chairman of the Board

Peter is a life sciences investor and serial entrepreneur focused on clinical diagnostics, contract research organizations, and scientific instruments. He currently serves as Chairman of Magellan Diagnostics, Dynex Technologies, Agilux Laboratories, and Blue Sky Bioservices. He is a Venture Partner at Ampersand Capital Partners, where he previously served as a General Partner.
Prior to Ampersand, he was CEO of Cohesive Technologies, a high throughput chromatography company that was acquired by Thermo Fisher, and President of Primedica Corporation, a preclinical CRO acquired by Charles River Laboratories.
Earlier in his career, Peter was VP of Corporate Development at Genzyme Transgenics Corporation, and a management consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from The Wharton School at the University of Pennsylvania.

Similar Profiles

Other People with this Name

Other people with the name Glick

Sally Glick
Sobel & Co. LLC

Jerrold Glick
Denver Union Station

David Glick
Triad EduPsych, PC

Danny Glick
Edusoft Ltd

Andrew Glick
Jewish Vocational Service Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory